RHUMBLINE ADVISERS

Position in MESO — Mesoblast Ltd

CIK 1115418 BOSTON, MA

Position in MESO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$106,251

-$13,851 QoQ

Shares Held

7,853

+0.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 72 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. MESO ranks #276 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$106,251	7,853	+0.6%	Shares	Sole	2026-08-12
2026-03-31	$120,102	7,809	+1.0%	Shares	Sole	2026-05-12
2025-12-31	$139,467	7,731	+50.9%	Shares	Sole	2026-02-13
2025-09-30	$82,547	5,124	-15.9%	Shares	Sole	2025-11-06
2025-06-30	$66,363	6,094	+4.5%	Shares	Sole	2025-08-12
2025-03-31	$72,795	5,833	-37.6%	Shares	Sole	2025-05-29
2024-12-31	$184,971	9,342	-15.5%	Shares	Sole	2025-05-29
2024-09-30	$90,319	11,055	+8.1%	Shares	Sole	2024-11-12
2024-06-30	$69,639	10,226	+12.7%	Shares	Sole	2024-08-01
2024-03-31	$45,470	9,076	-50.0%	Shares	Sole	2024-05-09
2023-12-31	$19,968	18,153	+4.7%	Shares	Sole	2024-02-08
2023-09-30	$21,319	17,333	+14.7%	Shares	Sole	2023-11-09
2023-06-30	$59,091	15,113	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.